Semaglutide and Blood Pressure: High & Low Readings

Blood pressure can change while you take semaglutide, but two different questions are often mixed together: what happened on average in research, and what today's reading means for you. Trials generally found lower blood pressure with the weight-management injection. A high reading, a faint spell or an unexpected low still needs its own assessment.

A number on a cuff cannot tell you whether semaglutide caused it. Your recent readings, symptoms, other medicines and any vomiting or diarrhea help the clinician decide what needs attention. Keep taking prescribed blood-pressure medicines unless your care team instructs otherwise.

What did the trials find?

STEP 1 compared once-weekly semaglutide 2.4 mg with placebo alongside lifestyle intervention in adults with overweight or obesity without diabetes¹. A later analysis used individual participant data from STEP 1, 3 and 4, covering 3,136 participants. The adjusted difference in systolic blood-pressure change favored semaglutide by 4.95 mmHg over the trials' 68-week periods².

That is the difference between groups, not a promise that your top number will fall by five points. The analysis linked much of the reduction to weight loss and also documented changes in antihypertensive treatment. It was not a trial proving that a standard blood-pressure prescription can be replaced with semaglutide².

These findings concern the 2.4 mg weekly injection. They should not be presented as an exact expected effect of the Wegovy tablet, Ozempic doses or every compounded preparation. Our heart-benefits guide covers a separate outcome: cardiovascular events rather than a cuff reading.

Can semaglutide cause low blood pressure?

Low blood pressure, drops on standing and fainting are recognized in Wegovy trial reporting. The label notes that some events occurred with gastrointestinal symptoms and volume loss, and low-pressure events were more frequent among people also taking antihypertensive medicines³.

That makes dizziness or feeling faint important to report, particularly during vomiting or diarrhea. It does not establish a universal need to reduce your blood-pressure dose. A clinician may need to review fluid status, readings and the full regimen. See dizziness on semaglutide and dehydration for those symptom patterns.

If you faint, are seriously unwell or have new chest, breathing or neurological symptoms, seek urgent medical help. Do not repeatedly stand up to test whether you still feel faint, or drive while dizzy. A routine home-monitoring plan is not a substitute for assessment during an acute illness.

What if your reading is high?

The average trial reduction does not rule out an individual high reading. Check measurement technique, record the result and contact your care team about readings that remain above the target they set. Do not take an extra pressure tablet or change semaglutide to correct a number on your own.

For a nonpregnant adult, AHA guidance treats a top number above 180 or a bottom number above 120 as severely high. If you have no new concerning symptoms, wait at least a minute and repeat; if it remains that high, contact a health professional immediately. With chest pain, shortness of breath, weakness, vision change, trouble speaking or other concerning symptoms, call 911 without waiting for it to fall⁵. Pregnancy needs its own urgent-care thresholds and plan; do not use this threshold to delay help.

How should you check at home?

AHA recommends a validated automatic upper-arm monitor with a correctly fitting cuff. For a routine reading, avoid smoking, caffeine and exercise for 30 minutes, empty your bladder, rest quietly for five minutes, and support the bare arm at heart level. Take two readings one minute apart and record them⁴.

Ask your clinician when and how often to measure rather than checking compulsively after every sensation. Bring the monitor and record to an appointment so technique and accuracy can be reviewed. These instructions are for routine monitoring; they should not delay emergency care for severe symptoms.

Does a faster pulse mean higher blood pressure?

No single pulse reading establishes your blood pressure. Wegovy's label separately describes a rise in resting heart rate and recommends monitoring³. Our heart-rate guide addresses that different measurement. Tell the team about palpitations rather than assuming the cuff reading explains them.

For longer-term care, agree on a target, a home-check schedule and what readings or symptoms should prompt a call. Any medication reduction should come from that review. Kidney disease can also shape the plan; Ozempic for kidney disease explains a distinct indication without replacing blood-pressure management.